For people with overweight, prediabetes or insulin resistance, sustainable weight loss and regular activity can improve glucose regulation and reduce progression risk. Treatment should be coordinated with a clinician, especially when diabetes medication is already used.
Know the markers
A1c, fasting glucose, blood pressure, triglycerides, waist circumference and family history help place risk in context. Symptoms alone cannot diagnose prediabetes or diabetes.
- Choose high-fiber carbohydrates
- Pair carbohydrate with protein
- Reduce sugar-sweetened drinks
- Walk after meals when appropriate
- Include resistance exercise
- Protect sleep duration and quality
Medication and glucose
Semaglutide and tirzepatide products have different brand indications. Ozempic and Mounjaro are diabetes brands; Wegovy and Zepbound are weight-management brands. A clinician should choose treatment based on diagnosis and the current prescribing information.
Avoid hypoglycemia risk
People using insulin or certain diabetes drugs may need closer monitoring as eating patterns or weight change. Do not change diabetes medication without the prescriber.
Affordable GLP-1 care in Brooklyn
Semaglutide-based options may start at $29.99/week+ and tirzepatide-based options at $45/week+ when insurance is accepted for qualifying visits. Self-pay options may start at $59.99/week+ and $69.99/week+, respectively.
Medical evaluation required. Eligibility, product, dose, pharmacy, availability, visit coverage and total cost vary. Brand-name products and compounded products are not equivalent; compounded drugs are not FDA-approved. Confirm current details before treatment.
W8MD Brooklyn office
Integrated services
Medical weight loss, GLP-1 evaluation, sleep medicine, home sleep studies, IV/IM nutrition and medical aesthetics.
Request information from W8MD Brooklyn
Ask about appointments, insurance, weight-loss options, sleep medicine or MedSpa services. Do not include sensitive medical or insurance identifiers.